Virtu Financial’s Bluejay Diagnostics BJDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-85
Closed -$12K 1388
2024
Q2
$12K Buy
85
+78
+1,114% +$65.5K ﹤0.01% 1106
2024
Q1
$9K Buy
+7
New +$9.65K ﹤0.01% 1256
2023
Q2
Hold
0
-$4K 1527
2023
Q1
Hold
0
1404
2022
Q3
Sell
-1
Closed -$45K 1741
2022
Q2
$45K Buy
+1
New +$35.5K ﹤0.01% 1150

Other funds holding BJDX

Virtu Financial's BJDX Position: Q3 2024 in Review

Virtu Financial sold out of Bluejay Diagnostics (BJDX) in Q3 2024, closing a stake of 85 shares — an estimated $12K sold.

Virtu Financial first reported a position in BJDX in Q2 2022 and held it in 3 quarters. The position peaked at $45K in Q2 2022. 11 funds tracked by Wall St. Rank hold BJDX as of Q3 2024.

  • Virtu Financial reported no remaining Bluejay Diagnostics position as of Q3 2024 after selling out during the quarter.
  • Virtu Financial sold 85 Bluejay Diagnostics shares in Q3 2024, an estimated $12K.
  • Virtu Financial first reported a position in Bluejay Diagnostics in Q2 2022 and held it in 3 quarters.
  • Virtu Financial's Bluejay Diagnostics position peaked at $45K in Q2 2022.
  • 11 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.